T M Sanger

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Olanzapine versus haloperidol treatment in first-episode psychosis
    T M Sanger
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Am J Psychiatry 156:79-87. 1999
  2. ncbi request reprint Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
    G D Tollefson
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Schizophr Res 35:S13-21. 1999
  3. ncbi request reprint Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study
    T M Sanger
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:273-81. 2001

Detail Information

Publications3

  1. ncbi request reprint Olanzapine versus haloperidol treatment in first-episode psychosis
    T M Sanger
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Am J Psychiatry 156:79-87. 1999
    ..Hence, the authors examined patients with first-episode psychosis to determine the efficacy and safety of olanzapine and haloperidol treatment...
  2. ncbi request reprint Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
    G D Tollefson
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Schizophr Res 35:S13-21. 1999
    ..This study concluded that the novel pharmacology of olanzapine delivered greater therapeutic activity in anxious and depressive symptoms accompanying schizophrenia than did the conventional dopamine D2 antagonist haloperidol...
  3. ncbi request reprint Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study
    T M Sanger
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:273-81. 2001
    ..Further double-blind, controlled studies are needed to confirm these results...